Looking for volunteers
A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
NCT06465719 · Second Affiliated Hospital, Zhejiang University, School of Medicine · Updated 8 Jan 2026
- What is being tested
- Minimally invasive basal ganglion hematoma evacuation with Tract-based AI Robot Guiding System; Patients will be managed with guideline-based medications
- For
- Basal Ganglia Hemorrhage
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 330 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 30 Sept 2025, ends 31 Dec 2027. Registered 20 June 2024.
- Results
- None posted yet.
In the researchers' words
A nationwide, prospective, multicenter randomized controlled clinical trial to evaluate the therapeutic effects of the fiber tract-based artificial intelligence (AI) Robot Guiding System on the perioperative and long-term recovery of patients with moderate-volume basal ganglion hemorrhage.
Sites
- the Second Affiliated Hospital of Zhejiang University School of MedicineHangzhou, Zhejiang, China